메뉴 건너뛰기




Volumn 95, Issue 10, 2010, Pages 4600-4608

Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

EID: 77957770822     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1831     Document Type: Article
Times cited : (34)

References (26)
  • 1
    • 57349156874 scopus 로고    scopus 로고
    • Recommendations for the diagnosis and management of Prader-Willi syndrome
    • speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS
    • Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS 2008 Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 93:4183-4197
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 4183-4197
    • Goldstone, A.P.1    Holland, A.J.2    Hauffa, B.P.3    Hokken-Koelega, A.C.4    Tauber, M.5
  • 2
    • 0030016685 scopus 로고    scopus 로고
    • Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome
    • Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M 1996 Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 9:393-400
    • (1996) J Pediatr Endocrinol Metab , vol.9 , pp. 393-400
    • Angulo, M.1    Castro-Magana, M.2    Mazur, B.3    Canas, J.A.4    Vitollo, P.M.5    Sarrantonio, M.6
  • 4
    • 0035719948 scopus 로고    scopus 로고
    • Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH
    • Burman P, Ritzén EM, Lindgren AC 2001 Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 22:787-799
    • (2001) Endocr Rev , vol.22 , pp. 787-799
    • Burman, P.1    Ritzén, E.M.2    Lindgren, A.C.3
  • 5
    • 77954800788 scopus 로고    scopus 로고
    • Endocrine disorders in children with Prader-Willi syndrome - Data from 142 children of the French database
    • Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H, Tauber M 2010 Endocrine disorders in children with Prader-Willi syndrome - data from 142 children of the French database. Horm Res Paediatr 74:121-128
    • (2010) Horm Res Paediatr , vol.74 , pp. 121-128
    • Diene, G.1    Mimoun, E.2    Feigerlova, E.3    Caula, S.4    Molinas, C.5    Grandjean, H.6    Tauber, M.7
  • 6
    • 0034523408 scopus 로고    scopus 로고
    • Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: Effect of GH therapy in 14 children
    • Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, Rochiccioli P 2000 Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res 53:279-287
    • (2000) Horm Res , vol.53 , pp. 279-287
    • Tauber, M.1    Barbeau, C.2    Jouret, B.3    Pienkowski, C.4    Malzac, P.5    Moncla, A.6    Rochiccioli, P.7
  • 8
    • 47949102974 scopus 로고    scopus 로고
    • Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: Experience from KIGS (Pfizer International Growth Database)
    • Lindgren AC, Lindberg A 2008 Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database). Horm Res 70:182-187
    • (2008) Horm Res , vol.70 , pp. 182-187
    • Lindgren, A.C.1    Lindberg, A.2
  • 9
    • 33847343358 scopus 로고    scopus 로고
    • Two years of growth hormone therapy in young children with Prader-Willi syndrome: Physical and neurodevelopmental benefits
    • Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB 2007 Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143:443-448
    • (2007) Am J Med Genet A , vol.143 , pp. 443-448
    • Myers, S.E.1    Whitman, B.Y.2    Carrel, A.L.3    Moerchen, V.4    Bekx, M.T.5    Allen, D.B.6
  • 10
    • 41849138910 scopus 로고    scopus 로고
    • Effects of growth hormone treatment in children presenting with Prader-Willi syndrome: The KIGS experience
    • Ranke MB, Price DA, Reiter EO, eds. Basel: Krager
    • Tauber M 2007 Effects of growth hormone treatment in children presenting with Prader-Willi syndrome: the KIGS experience. In: Ranke MB, Price DA, Reiter EO, eds. Growth hormone therapy in paediatrics - 20 years of KIGS. Basel: Krager; 377-388
    • (2007) Growth Hormone Therapy in Paediatrics - 20 Years of KIGS , pp. 377-388
    • Tauber, M.1
  • 11
    • 0028958031 scopus 로고
    • Insulin-like growth factors and their binding proteins: Biological actions
    • Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
    • (1995) Endocr Rev , vol.16 , pp. 3-34
    • Jones, J.I.1    Clemmons, D.R.2
  • 12
    • 1942436958 scopus 로고    scopus 로고
    • Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis
    • Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
    • (2004) Lancet , vol.363 , pp. 1346-1353
    • Renehan, A.G.1    Zwahlen, M.2    Minder, C.3    O'Dwyer, S.T.4    Shalet, S.M.5    Egger, M.6
  • 13
    • 64249111139 scopus 로고    scopus 로고
    • Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
    • Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM 2009 Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124:2416-2429
    • (2009) Int J Cancer , vol.124 , pp. 2416-2429
    • Rowlands, M.A.1    Gunnell, D.2    Harris, R.3    Vatten, L.J.4    Holly, J.M.5    Martin, R.M.6
  • 14
    • 2342525088 scopus 로고    scopus 로고
    • Cancer risk following growth hormone use in childhood: Implications for current practice
    • Ogilvy-Stuart AL, Gleeson H 2004 Cancer risk following growth hormone use in childhood: implications for current practice. Drug Saf 27:369-382
    • (2004) Drug Saf , vol.27 , pp. 369-382
    • Ogilvy-Stuart, A.L.1    Gleeson, H.2
  • 16
    • 0038030751 scopus 로고    scopus 로고
    • Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome
    • Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH 2003 Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88:2206-2212
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 2206-2212
    • Haqq, A.M.1    Stadler, D.D.2    Jackson, R.H.3    Rosenfeld, R.G.4    Purnell, J.Q.5    LaFranchi, S.H.6
  • 19
    • 0014525649 scopus 로고
    • Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
    • Usher R, McLean F 1969 Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 74:901-910
    • (1969) J Pediatr , vol.74 , pp. 901-910
    • Usher, R.1    McLean, F.2
  • 22
    • 0014899071 scopus 로고
    • Standards for children's height at ages 2-9 years allowing for heights of parents
    • Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 45:755-762
    • (1970) Arch Dis Child , vol.45 , pp. 755-762
    • Tanner, J.M.1    Goldstein, H.2    Whitehouse, R.H.3
  • 24
    • 0029121073 scopus 로고
    • Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation
    • Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534-2542
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 2534-2542
    • Juul, A.1    Dalgaard, P.2    Blum, W.F.3    Bang, P.4    Hall, K.5    Michaelsen, K.F.6    Müller, J.7    Skakkebaek, N.E.8
  • 25
    • 33746054604 scopus 로고    scopus 로고
    • Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database)
    • on behalf of the KIGS International Board
    • Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Wikland KA, Ranke MB, Price DA, on behalf of the KIGS International Board 2006 Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol 65:178-185
    • (2006) Clin Endocrinol , vol.65 , pp. 178-185
    • Craig, M.E.1    Cowell, C.T.2    Larsson, P.3    Zipf, W.B.4    Reiter, E.O.5    Wikland, K.A.6    Ranke, M.B.7    Price, D.A.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.